Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo

Cancer Immunology, Immunotherapy

Volumn 55, Issue 1, 2006, Pages 31-38

  Schmidt, Jan ^a   Klempp, Christoph ^a   Büchler, Markus W ^a   Märten, Angela ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Apoptosis; Dendritic cells; iC3b; Tolerance

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3B RECEPTOR; FLUOROURACIL; N ACETYLGLUCOSAMINE; RECOMBINANT ALPHA INTERFERON; TRASTUZUMAB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL ADHESION; CELL MATURATION; CELL SECRETION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOTOXICITY; DENDRITIC CELL; FLOW CYTOMETRY; HEAT STRESS; HUMAN; HUMAN CELL; IMMUNOCOMPETENCE; IMMUNOLOGICAL TOLERANCE; MOLECULAR INTERACTION; MONOCYTE; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RECEPTOR BINDING; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, NEOPLASM; APOPTOSIS; BINDING SITES; CARCINOMA; CELL DIFFERENTIATION; COMPLEMENT C3B; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNE TOLERANCE; IMMUNOCOMPETENCE; LYMPHOCYTE ACTIVATION; MICE; PANCREATIC NEOPLASMS; SERUM; TUMOR CELLS, CULTURED;

EID: 28944439994     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-005-0690-5     Document Type: Article

References (15)

1. Albanell J, Codony J, Rovira A, Mellado B, Gascon P (2003) Mechanism of action of anti-HER2 monoclonal antibodies: scientific update on trastuzumab and 2C4. Adv Exp Med Biol 532:253
2. Albert ML (2004) Death-defying immunity: do apoptotic cells influence antigen processing and presentation? Nat Rev Immunol 4:223
3. Fong L, Engleman EG (2000) Dendritic cells in cancer immunotherapy. Annu Rev Immunol 18:245
4. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20:621
5. Junnikkala S, Hakulinen J, Jarva H, Manuelian T, Bjorge L, Butzow R, Zipfel PF, Meri S (2002) Secretion of soluble complement inhibitors factor H and factor H-like protein (FHL-1) by ovarian tumour cells. Br J Cancer 87:1119
6. Menard S, Pupa SM, Campiglio M, Tagliabue E (2003) Biologic and therapeutic role of HER2 in cancer. Oncogene 22:6570
7. Morelli AE, Larregina AT, Shufesky WJ, Zahorchak AF, Logar AJ, Papworth GD, Wang Z, Watkins SC, Falo LD Jr, Thomson AW (2003) Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101:611
8. Ramos OF, Kai C, Yefenof E, Klein E (1988) The elevated natural killer sensitivity of targets carrying surface-attached C3 fragments require the availability of the iC3b receptor (CR3) on the effectors. J Immunol 140:1239
9. Reinhard G, Märten A, Kiske SM, Feil F, Bieber T, Schmidt-Wolf IG (2002) Generation of dendritic cell-based vaccines for cancer therapy. Br J Cancer 86:1529
10. Sohn JH, Bora PS, Suk HJ, Molina H, Kaplan HJ, Bora NS (2003) Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nat Med 9:206
11. Steinman R (1991) The dendritic cell system and it's role in immunogenicity. Annu Rev Immunol 9:271
12. Steinman RM, Pope M (2002) Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest 109:1519
13. Steinman RM, Turley S, Mellman I, Inaba K (2000) The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 191:411
14. Takizawa F, Tsuji S, Nagasawa S (1996) Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett 397:269
15. Verbovetski I, Bychkov H, Trahtemberg U, Shapira I, Hareuveni M, Ben-Tal O, Kutikov I, Gill O, Mevorach D (2002) Opsonization of apoptotic cells by autologous iC3b facilitates clearance by immature dendritic cells, down-regulates DR and CD86, and up-regulates CC chemokine receptor 7. J Exp Med 196:1553